Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
Christina Ornauer, Vice President, Head of Medical Affairs of Hematology Europe at Avanzanite Bioscience, shared a post on LinkedIn:
“Attending EHA 2026 was truly inspiring, as I connected with dedicated colleagues, researchers, and healthcare professionals focused on advancing patient care.
The congress showcased the remarkable pace of innovation in hematology and emphasized the importance of collaboration within the healthcare community.
I am grateful for the opportunity to learn, exchange perspectives, and bring new insights back to my work.
Thank you to everyone who shared their expertise and passion throughout the meeting.
I look forward to seeing how these advances continue to shape the future for patients.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn RuksakulpiwatÖ‰ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin